Results 161 to 170 of about 729,299 (226)

Plasminogen activator inhibitor-1 as an oncologic target: biology, therapeutic inhibitors, and clinical translation. [PDF]

Front Oncol
Al Shaer NSH, Tleyjeh A, Al-Attas MA, Alibrahim JH, Khan MI, Yaqinuddin A.   +5 more
europepmc   +1 more source

Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies. [PDF]

Transl Oncol
Wang CC, Barkholt P, Wozniak A, Vanleeuw U, Lee CJ, De Sutter L, De Cock L, Verbeeck K, Engelholm LH, Lynch C, Mumberg D, Schöffski P.   +11 more
europepmc   +1 more source

Prospective validation of the prognostic and predictive impact of uPA/PAI-1 in early breast cancer. [PDF]

Breast Cancer Res Treat
Wieder V, Engel J, Eichstädt K, Kaufhold S, Bauer M, Hanf V, Uleer C, Peschel S, John J, Pöhler M, Lantzsch T, Weigert E, Bürrig KF, Buchmann J, Kantelhardt EJ, Thomssen C, Vetter M.   +16 more
europepmc   +1 more source

Fibrinolysis-unrelated functions of the plasminogen/plasmin system: A gateway to successful parasitism? [PDF]

Curr Res Parasitol Vector Borne Dis
Serrat J, Siles-Lucas M, González-Miguel J.   +2 more
europepmc   +1 more source

Identification of a robust multitarget protein panel for Parkinson's disease via absolute quantification and large-scale external replication. [PDF]

Brain Commun
Lee HW, Choi Y, Lee S, Kim JE, Jeon MT, Jo M, Park G, Park JS, Kim DG, Cheon M, Kim HJ.   +10 more
europepmc   +1 more source

Beyond Direct Fibrinolysis: Novel Approaches to Thrombolysis. [PDF]

Pharmaceuticals (Basel)
Shibeko AM, Nikitin NS, Podoplelova NA, Manuvera VA, Lazarev VN.   +4 more
europepmc   +1 more source

Evaluating plasma ferritin and suPAR as treatable traits for critically ill patients with COVID-19 treated with anakinra: an exploratory analysis of the immune modulation domain of the REMAP-CAP randomised clinical trial. [PDF]

Crit Care
Boyle AJ, Ryan EG, Berry LR, Berry S, Derde L, Lawler PR, Lorenzi E, O'Kane CM, Shankar-Hari M, Veerdonk FV, Gordon AC, McAuley DF, REMAP-CAP Immune Modulation Domain Investigators.   +12 more
europepmc   +1 more source

Presumed Mechanisms Underlying Lipoprotein(a)-caused Atherosclerosis. [PDF]

Eur Cardiol
Filtz A, Slipczuk L, Gulati M.
europepmc   +1 more source

Echocardiography and inflammatory biomarkers for predicting mortality and major adverse cardiovascular events in type 1 diabetes. [PDF]

Cardiovasc Diabetol
Bahrami HSZ, Jørgensen PG, Hove JD, Dixen U, Rasmussen LJH, Eugen-Olsen J, Rossing P, Jensen MT.   +7 more
europepmc   +1 more source